文献速递胃肠动力与功能性疾病

肠易激综合征肠道化学敏感性与小肠TRPV通道表达相关

Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression.
PubMed 文献 · Aliment Pharmacol Ther · 2021-09-02

研究纳入26例IBS患者(12例IBS-C,14例IBS-D)和15名健康志愿者,评估脂质灌注后症状、直肠敏感性和小肠TRPV通道表达。脂质灌注后IBS患者症状应答更强,IBS-C和IBS-D直肠感觉阈值低于健康志愿者;IBS-D十二指肠TRPV1和TRPV3表达增高,IBS-C TRPV3增高,TRPV1表达与腹痛及直肠阈值相关。

要点

  • 脂质灌注后IBS患者较健康志愿者更易出现疼痛、恶心、饱胀和便急感。
  • IBS-C和IBS-D患者直肠感觉和疼痛阈值低于健康志愿者。
  • 十二指肠TRPV1表达与腹痛正相关,与直肠感觉和疼痛阈值负相关。

核心结论

  • 脂质灌注在IBS患者中引起比健康志愿者更强的症状应答,该应答与小肠TRPV通道表达相关。
  • TRPV介导的小肠化学敏感性可能介导IBS餐后症状。

研究设计与样本

  • 招募26例IBS患者(12例IBS-C,14例IBS-D)和15名健康志愿者(HV)。
  • 采用糖排泄试验评估体内通透性,直肠恒压器评估直肠敏感性,脂质灌注前后进行。
  • 进行延长上消化道内镜联合探头共聚焦激光显微内镜(pCLE)观察脂质诱导变化,并获取十二指肠和空肠黏膜活检行转录组学分析。

主要发现

  • 脂质灌注后,报告无疼痛、无恶心、无饱胀和无便急感的HV比例高于IBS患者(P < 0.05 for all)。
  • 在校正性别和焦虑的模型中,IBS-C和IBS-D患者首次直肠感觉阈值(P = 0.0007)和疼痛阈值(P = 0.004)低于HV。
  • 体内小肠通透性和平均pCLE评分在IBS患者与HV间相似;脂质灌注后pCLE评分高于脂质前,但组间无差异。
  • 基线十二指肠TRPV1和TRPV3表达在IBS-D中增高,TRPV3在IBS-C中增高。
  • 十二指肠TRPV1表达与腹痛相关(r = 0.51,FDR = 0.01),与首次直肠感觉阈值(r = -0.48,FDR = 0.01)和疼痛阈值(r = -0.41,FDR = 0.02)呈负相关。

临床怎么用

  • IBS患者餐后症状可能与小肠TRPV通道介导的化学敏感性有关,提示TRPV通道或为潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Irritable bowel syndrome (IBS) patients often experience meal-associated symptoms. However, the underlying mechanisms are unclear. AIM: To determine small intestinal mechanisms of lipid-induced symptoms and rectal hypersensitivity in IBS METHODS: We recruited 26 IBS patients (12 IBS-C, 14 IBS-D) and 15 healthy volunteers (HV). In vivo permeability was assessed using saccharide excretion assay. Rectal sensitivity was assessed using a barostat before and after small bowel lipid infusion; symptoms were assessed throughout. Next, an extended upper endoscopy with probe-based confocal laser endomicroscopy (pCLE) was performed with changes induced by lipids. Duodenal and jejunal mucosal biopsies were obtained for transcriptomics. RESULTS: Following lipid infusion, a higher proportion of HV than IBS patients reported no pain, no nausea, no fullness and no urgency (P < 0.05 for all). In a model adjusted for sex and anxiety, IBS-C and IBS-D patients had lower thresholds for first rectal sensation (P = 0.0007) and pain (P = 0.004) than HV. In vivo small intestinal permeability and mean pCLE scores were similar between IBS patients and HV. Post-lipid, pCLE scores were higher than pre-lipid but were not different between groups. Baseline duodenal transient receptor potential vanilloid (TRPV) 1 and 3 expression was increased in IBS-D, and TRPV3 in IBS-C. Duodenal TRPV1 expression correlated with abdominal pain (r = 0.51, FDR = 0.01), and inversely with first rectal sensation (r = -0.48, FDR = 0.01) and pain (r = -0.41, FDR = 0.02) thresholds. CONCLUSION: Lipid infusion elicits a greater symptom response in IBS patients than HV, which is associated with small intestinal expression of TRPV channels. TRPV-mediated small intestinal chemosensitivity may mediate post-meal symptoms in IBS.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Grover M, Berumen A, Peters S, et al. Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression. Aliment Pharmacol Ther. 2021. PMID: 34472640. doi:10.1111/apt.16591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。